FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Sulfacetamide sodium 100 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sulfacetamide sodium 100 mg/g eye ointment Count of base of active ingredient False 1 Inferred relationship Some
    Estradiol 2.5 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Estradiol 2.5 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Triamcinolone diacetate 25 mg/mL suspension for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Triamcinolone diacetate 25 mg/mL suspension for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 3
    Bupivacaine hydrochloride 1.05 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Bupivacaine hydrochloride 1.05 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Esmolol hydrochloride 250 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Esmolol hydrochloride 250 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ketotifen 200 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ketotifen 200 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation Count of base of active ingredient False 1 Inferred relationship Some
    Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Sulfafurazole 100 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sulfafurazole 100 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Ergometrine 200 microgram/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Ergometrine 200 microgram/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Hydralazine hydrochloride 20 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Hydralazine hydrochloride 20 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Sulfacetamide sodium 200 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Sulfacetamide sodium 200 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 2
    Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream Count of base of active ingredient False 1 Inferred relationship Some
    Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream Has concentration strength denominator value False 1 Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 2
    Estradiol 3.13 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Estradiol 3.13 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sulfacetamide sodium 60 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sulfacetamide sodium 60 mg/g eye ointment Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel Has concentration strength denominator value False 1 Inferred relationship Some 2
    Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Prochlorperazine 1 mg/mL oral solution Has concentration strength numerator value False 1 Inferred relationship Some 1
    Prochlorperazine 1 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Prochlorperazine 1 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Trimethobenzamide hydrochloride 100 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1

    Start Previous Page 189 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start